Sanfilippo John B & Son (JBSS) grows EPS and $1.18B snack sales
Rhea-AI Filing Summary
SANFILIPPO JOHN B & SON INC (JBSS) furnished an investor presentation highlighting long-term growth, recent performance, and strategy as a leading U.S. nut and snack manufacturer. For FY 2026, net sales were $1.18 billion with EBITDA of $113.6 million and an EBITDA margin of 9.7%, on 349.3 million pounds sold.
Diluted EPS increased from $2.68 in FY 2016 to $5.26 in FY 2026, a 7.0% CAGR, while average daily stock price rose from $56.13 to $71.83. The consumer channel generated $960 million of FY 2026 net sales, up 6% versus FY 2025; commercial ingredients reached $120 million (+10%), and contract manufacturing $95 million (+4%). JBSS emphasizes private label and branded growth, especially in snack and nutrition bars, where installed bar lines add 64 million pounds of capacity. Financial position metrics show FY 2026 net working capital of $181.4 million and return on equity of 16.3%, supporting continued dividends and elevated capital investment.
Positive
- Diluted EPS grew from $2.68 to $5.26 between FY 2016 and FY 2026, a 7.0% CAGR, indicating strong long-term earnings expansion.
- EBITDA reached $113.6 million in FY 2026 with a 9.7% EBITDA margin, reflecting improved profitability versus earlier years.
- Consumer channel net sales were $960 million in FY 2026, up 6% versus FY 2025, showing healthy growth in the core distribution channel.
- Commercial ingredients net sales grew to $120 million in FY 2026, a 10% increase versus FY 2025, highlighting momentum in this segment.
- Return on equity improved to 16.3% in FY 2026 from 12.1% in FY 2016, demonstrating stronger capital efficiency over time.
Negative
- None.
Insights
Analyzing...
8-K Event Classification
Key Figures
Key Terms
EBITDA financial
EBITDA Margin financial
Net Working Capital financial
Debt to EBITDA financial
Private Label financial
FAQ
What were JBSS (John B. Sanfilippo & Son, Inc.) net sales and EBITDA in FY 2026?
How important is the consumer channel to JBSS revenues in FY 2026?
What growth did JBSS report in commercial ingredients and contract manufacturing for FY 2026?
What does the JBSS presentation say about bar category investments and capacity?
How strong is JBSS balance sheet and return profile as of FY 2026?
AI-generated analysis. How Rhea-AI works. Not financial advice.




























